MediFind
Condition

Familial Lipoprotein Lipase Deficiency

Active Clinical Trials

Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 16
  • Start Date: December 9, 2019
Postprandial Fatty Acid Metabolism in Subjects With Lipoprotein Lipase Deficiency
Clinical Trial
Drug
  • Status: Active, not recruiting
  • Study Type: Drug
  • Participants: 2
  • Start Date: December 2015
Orlistat for the Treatment of Type I Hyperlipoproteinemia
Clinical Trial
Other
  • Status: Active, not recruiting
  • Study Type: Other
  • Participants: 16
  • Start Date: June 27, 2014
Glybera Registry, Long-term Safety and Efficacy Follow-up in Lipoprotein Lipase Deficient (LPLD) Patients Treated With Alipogene Tiparvovec (GLYBERA®)